TCX · Tucows Inc /Pa/
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-06-02 | Tory Jeffrey Stewart Donald |
Director |
Award↑
|
Stock Option (Right to Buy)
|
3,750 |
| 2026-06-02 | Uhrenbacher Christian Stephan |
Director |
Award↑
|
Stock Option (right to buy)
|
3,750 |
| 2026-06-02 | Nienaber Laurenz Malte |
Director |
Award↑
|
Stock Option (Right to Buy)
|
3,750 |
| 2026-06-02 | Matz-Cerf Sandra Carola |
Director |
Award↑
|
Stock Option (Right to Buy)
|
3,750 |
| 2026-06-02 | Taylor Allen Gordon |
Director |
Award↑
|
Stock Option (right to buy)
|
3,750 |
| 2026-06-02 | Carl Marlene |
Director |
Award↑
|
Stock Option (Right to Buy)
|
3,750 |
| 2026-06-02 | Matheson Lee |
Director |
Award↑
|
Stock Option (Right to buy)
|
3,750 |
| 2025-12-24 | NOSS ELLIOT |
Director |
Gift↓
Filing footnotes — Common Stock (Direct)
The transaction reflects a bona fide gift to a charitable organization. |
Common Stock
|
20,250 |
| 2025-11-26 | Woroch David John |
Chief Executive Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Stock options granted under the 2006 Equity Compensation Plan vest in four (4) equal installments of 25% each beginning on the first anniversary of the grant date. |
Stock Option (Right to Buy)
|
20,000 |
| 2025-09-08 | Ivanov Ivan |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Stock options granted under the 2006 Equity Compensation Plan vest in four (4) equal installments of 25% each beginning on the first anniversary of the grant date. |
Stock Option (Right to Buy)
|
20,000 |
| 2025-07-17 | NOSS ELLIOT |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023, at least ninety days prior to the trading date. |
Common Stock
|
500 |
| 2025-07-11 | NOSS ELLIOT |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023, at least ninety days prior to the trading date. These shares were sold in multiple transactions, at prices ranging from $22.65 to $23.38. The reporting person will provide to the Commission, the Issuer, and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. |
Common Stock
|
700 |
| 2025-07-10 | NOSS ELLIOT |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023, at least ninety days prior to the trading date. These shares were sold in multiple transactions, each at the price of $22.44. The reporting person will provide to the Commission, the Issuer, and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. |
Common Stock
|
400 |
| 2025-07-10 | NOSS ELLIOT |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023, at least ninety days prior to the trading date. These shares were sold in multiple transactions, at prices ranging from $21.41 to $22.33. The reporting person will provide to the Commission, the Issuer, and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. |
Common Stock
|
1,600 |
| 2025-07-09 | NOSS ELLIOT |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023, at least ninety days prior to the trading date. |
Common Stock
|
500 |
| 2025-07-08 | NOSS ELLIOT |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023, at least ninety days prior to the trading date. These shares were sold in multiple transactions, at prices ranging from $20.66 to $20.91. The reporting person will provide to the Commission, the Issuer, and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. |
Common Stock
|
2,500 |
| 2025-07-07 | NOSS ELLIOT |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023, at least ninety days prior to the trading date. These shares were sold in multiple transactions, at prices ranging from $20.48 to $20.52. The reporting person will provide to the Commission, the Issuer, and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. |
Common Stock
|
2,600 |
| 2025-07-02 | NOSS ELLIOT |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023, at least ninety days prior to the trading date. These shares were sold in multiple transactions, at prices ranging from $20.39 to $20.58. The reporting person will provide to the Commission, the Issuer, and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. |
Common Stock
|
3,200 |
| 2025-06-05 | Fausett Bret |
Chief Legal Officer & VP |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Stock options granted under the 2006 Equity Compensation Plan vest in four (4) equal installments of 25% each beginning on the first anniversary of the grant date. |
Stock Option (Right to Buy)
|
1,125 |
| 2025-06-05 | Woroch David John |
Chief Executive Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Stock options granted under the 2006 Equity Compensation Plan vest in four (4) equal installments of 25% each beginning on the first anniversary of the grant date. |
Stock Option (Right to Buy)
|
2,250 |
| 2025-06-05 | NOSS ELLIOT |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Stock options granted under the 2006 Equity Compensation Plan vest in four (4) equal installments of 25% each beginning on the first anniversary of the grant date. |
Stock Option (right to buy)
|
4,500 |
| 2025-05-22 | Matz-Cerf Sandra Carola |
Director |
Award↑
|
Stock Option (Right to Buy)
|
2,500 |
| 2025-05-22 | Uhrenbacher Christian Stephan |
Director |
Award↑
|
Stock Option (right to buy)
|
5,000 |
| 2025-05-22 | Taylor Allen Gordon |
Director |
Award↑
|
Stock Option (right to buy)
|
6,250 |
| 2025-05-22 | Tory Jeffrey Stewart Donald |
Director |
Award↑
|
Stock Option (Right to Buy)
|
3,750 |
| 2025-05-22 | Nienaber Laurenz Malte |
Director |
Award↑
|
Stock Option (Right to Buy)
|
2,500 |
| 2025-05-20 | Nienaber Laurenz Malte |
Director |
Award↑
|
Stock Option (Right to Buy)
|
4,375 |
| 2025-05-20 | Taylor Allen Gordon |
Director |
Award↑
|
Stock Option (right to buy)
|
4,375 |
| 2025-05-20 | Tory Jeffrey Stewart Donald |
Director |
Award↑
|
Stock Option (Right to Buy)
|
4,375 |
| 2025-05-20 | Matz-Cerf Sandra Carola |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2025-05-20 | Uhrenbacher Christian Stephan |
Director |
Award↑
|
Stock Option (right to buy)
|
4,375 |
| 2025-05-20 | Matheson Lee |
Director |
Award↑
|
Stock Option (Right to buy)
|
3,750 |
| 2025-05-20 | Matz-Cerf Sandra Carola |
Director |
Award↑
|
Stock Option (Right to Buy)
|
4,375 |
| 2025-05-20 | Carl Marlene |
Director |
Award↑
|
Stock Option (Right to Buy)
|
3,750 |
| 2025-05-15 | NOSS ELLIOT |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023, at least ninety days prior to the trading date. These shares were sold in multiple transactions with prices ranging from $17.36 to $18.04. The reporting person will provide to the Commission, the Issuer, and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. |
Common Stock
|
3,000 |
| 2025-05-14 | NOSS ELLIOT |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023, at least ninety days prior to the trading date. These shares were sold in multiple transactions, all at the price of 17.35. The reporting person will provide to the Commission, the Issuer, and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. |
Common Stock
|
500 |
| 2025-05-09 | NOSS ELLIOT |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023, at least ninety days prior to the trading date. |
Common Stock
|
100 |
| 2025-05-08 | NOSS ELLIOT |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023, at least ninety days prior to the trading date. These shares were sold in multiple transactions at prices ranging from $17.07 to $17.60. The reporting person will provide to the Commission, the Issuer, and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. |
Common Stock
|
1,600 |
| 2025-05-07 | NOSS ELLIOT |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023, at least ninety days prior to the trading date. These shares were sold in multiple transactions at prices ranging from $16.38 to $16.44. The reporting person will provide to the Commission, the Issuer, and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. |
Common Stock
|
700 |
| 2025-05-06 | NOSS ELLIOT |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023, at least ninety days prior to the trading date. These shares were sold in multiple transactions at prices ranging from $16.27 to $16.34. The reporting person will provide to the Commission, the Issuer, and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. |
Common Stock
|
700 |
| 2025-05-05 | NOSS ELLIOT |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023, at least ninety days prior to the trading date. These shares were sold in multiple transactions at prices ranging from $16.07 to $16.27. The reporting person will provide to the Commission, the Issuer, and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. |
Common Stock
|
800 |
| 2025-04-24 | NOSS ELLIOT |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023, at least ninety days prior to the trading date. |
Common Stock
|
500 |
| 2025-04-23 | NOSS ELLIOT |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023, at least ninety days prior to the trading date. |
Common Stock
|
500 |
| 2025-04-22 | NOSS ELLIOT |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023, at least ninety days prior to the trading date. |
Common Stock
|
500 |
| 2025-04-17 | NOSS ELLIOT |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023, at least ninety days prior to the trading date. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.46. The reporting person will provide to the Commission, the Issuer, and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. |
Common Stock
|
1,000 |
| 2025-04-14 | NOSS ELLIOT |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023, at least ninety days prior to the trading date. These shares were sold in multiple transactions at prices ranging from $16.10 to $16.45. The reporting person will provide to the Commission, the Issuer, and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price |
Common Stock
|
1,000 |
| 2025-04-11 | NOSS ELLIOT |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023, at least ninety days prior to the trading date. These shares were sold in multiple transactions at prices ranging from $15.18 to $16.11. The reporting person will provide to the Commission, the Issuer, and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. |
Common Stock
|
1,000 |
| 2025-04-09 | NOSS ELLIOT |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023, at least ninety days prior to the trading date. These shares were sold in multiple transactions at prices ranging from $15.02 to $15.03. The reporting person will provide to the Commission, the Issuer, and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. |
Common Stock
|
300 |
| 2025-04-07 | NOSS ELLIOT |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023, at least ninety days prior to the trading date. These shares were sold in multiple transactions at prices ranging from $15.44 to $15.45. The reporting person will provide to the Commission, the Issuer, and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. |
Common Stock
|
500 |
| 2025-04-04 | NOSS ELLIOT |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023, at least ninety days prior to the trading date. These shares were sold in multiple transactions at prices ranging from $16.20 to $16.25. The reporting person will provide to the Commission, the Issuer, and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. |
Common Stock
|
1,000 |